The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)7-8
Number of pages2
JournalBritish Journal of Haematology
Issue number1
Publication statusPublished - Jan 1 2018


  • chronic lymphocytic leukaemia
  • haematological malignancy
  • oncological intervention

ASJC Scopus subject areas

  • Hematology

Cite this